全文获取类型
收费全文 | 66篇 |
免费 | 2篇 |
专业分类
儿科学 | 3篇 |
妇产科学 | 2篇 |
基础医学 | 3篇 |
临床医学 | 4篇 |
内科学 | 9篇 |
特种医学 | 10篇 |
外科学 | 9篇 |
预防医学 | 1篇 |
药学 | 1篇 |
肿瘤学 | 26篇 |
出版年
2024年 | 1篇 |
2023年 | 3篇 |
2022年 | 2篇 |
2021年 | 1篇 |
2020年 | 4篇 |
2019年 | 3篇 |
2018年 | 2篇 |
2017年 | 4篇 |
2016年 | 2篇 |
2015年 | 4篇 |
2014年 | 3篇 |
2012年 | 9篇 |
2011年 | 2篇 |
2010年 | 2篇 |
2009年 | 3篇 |
2007年 | 3篇 |
2006年 | 1篇 |
2005年 | 3篇 |
2004年 | 2篇 |
2003年 | 2篇 |
1993年 | 1篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1975年 | 1篇 |
1970年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有68条查询结果,搜索用时 15 毫秒
41.
Salvioni R Nicolai N Necchi A Torelli T Piva L Stagni S Catanzaro MA Biasoni D Milani A Colecchia M Spreafico C Morosi C Marchianò A Crippa F 《Urologia》2012,79(2):81-88
The treatment of tumors of the testis represents an ideal model of care for cancer. Many different, intersecting strategies are available for managing germ-cell cancers, particularly in the early-stage disease. Which is 'right' remains a matter of debate, and requires balancing efficacy against late effects, bearing in mind the complexity of treatment strategies and the available expertise. The cornerstone of this model of success is linked to the quality and appropriateness of care. The current therapeutic strategy is very complex (Fig. 1). High-tech surgery, medical oncology and radiotherapy are involved at various levels of diagnostic techniques of the latest generation. The choice of therapy, alone or integrated, is often influenced by prognostic factors. In this article we will examine the important points and sometimes the subject of controversy in both diagnosis and treatment of these early-stage tumors (Clinical Stage I: disease confined to the testis; Clinical Stage IIA: retroperitoneal lymph nodes < 2 cm). 相似文献
42.
Drug‐eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma 下载免费PDF全文
43.
Mosconi G Di Rosa I Bucci S Morosi L Franzoni MF Polzonetti-Magni AM Pascolini R 《General and comparative endocrinology》2005,142(3):318-324
Some chemical compounds used in intensive agriculture have been found to induce estrogenic effects; therefore a histological analysis of the testes and an evaluation of plasma levels of sex steroid, thyroid hormones, and vitellogenin were carried out in adult male water frogs of two coexisting taxa (Rana lessonae and the hemiclonal hybrid Rana esculenta) sampled in agricultural and pristine areas. Differences in seasonal profiles of hormones were found in water frogs living in the agricultural area where the presence of endocrine disrupting compounds was suspected on the basis of a previous study. In R. esculenta, sampled in the pristine area, high androgen levels were found in May; the opposite trend was found for R. esculenta sampled in agricultural areas in which the highest androgen levels were found in September, significantly lower compared with those found in R. esculenta sampled in the pristine area. Low androgen levels were also recorded in R. lessonae males sampled both in pristine and agricultural areas, while the highest levels were found in September. Regarding the trend of estradiol-17beta, an increase of this hormone was found in July both in esculenta and lessonae sampled in the agricultural area, and in the same month an estradiol-17beta peak, even though lower, was also found both in esculenta and lessonae males captured in the pristine area; detectable vitellogenin was found neither in males captured in the agricultural area, nor in those sampled in the pristine one. Moreover, while no significant changes of thyroid hormones were found either in the esculenta or lessonae males sampled in the pristine area, increased T3 and T4 titers were found in July in both esculenta and lessonae captured in the agricultural area. Morphological differences of the testes in males of parental species captured in the agricultural area were also observed. These findings indicate alterations in endocrine and reproductive function in frogs in the agricultural area, that could suggest the presence of endocrine disrupting compounds. 相似文献
44.
C. Chiesa M. Mira M. Maccauro C. Spreafico R. Romito C. Morosi T. Camerini M. Carrara S. Pellizzari A. Negri G. Aliberti C. Sposito S. Bhoori A. Facciorusso E. Civelli R. Lanocita B. Padovano M. Migliorisi M. C. De Nile E. Seregni A. Marchianò F. Crippa V. Mazzaferro 《European journal of nuclear medicine and molecular imaging》2015,42(11):1718-1738
45.
Giacomo Giulio Baldi Mehdi Brahmi Salvatore Lo Vullo Elena Cojocaru Olivier Mir Michela Casanova Bruno Vincenzi Tommaso Martino De Pas Giovanni Grignani Maria Abbondanza Pantaleo Jean Yves Blay Robin Lewis Jones Axel Le Cesne Anna Maria Frezza Alessandro Gronchi Paola Collini Angelo Paolo Dei Tos Carlo Morosi Luigi Mariani Paolo Giovanni Casali Silvia Stacchiotti 《The oncologist》2020,25(11):e1777-e1784
46.
Giacomo G. Baldi MD Salvatore Lo Vullo MD Giovanni Grignani MD Bruno Vincenzi MD Giuseppe Badalamenti MD Marinella Mastore MD Ciriaco Buonomenna MD Carlo Morosi MD Marta Barisella MD Anna Maria Frezza MD Salvatore Provenzano MD Noemi Simeone MD Fernanda Picozzi MD Luigi Mariani MD Paolo G. Casali MD Silvia Stacchiotti MD 《Cancer》2022,128(7):1439-1448
47.
Michela Casanova Luca Bergamaschi Stefano Chiaravalli Carlo Morosi Virginia Livellara Shushan Hovsepyan Giovanna Sironi Nadia Puma Olga Nigro Giovanna Gattuso Roberto Luksch Monica Terenziani Filippo Spreafico Cristina Meazza Marta Podda Veronica Biassoni Elisabetta Schiavello Patrizia Gasparini Sabina Vennarini Maura Massimino Andrea Ferrari 《Pediatric blood & cancer》2023,70(2):e30095
48.
49.
50.
Chiara Giraudo MD PhD Reineke Schoot MD PhD Liesbeth Cardoen MD Roberto Stramare MD Beatrice Coppadoro BSc Gianni Bisogno MD Amine Bouhamama MD Bernadette Brennan MD Herve J. Brisse MD Daniel Orbach MD Ana Coma MD Pier Luigi Di Paolo MD Cindy Fayard MD Leigh McDonald MD Salma Moalla MD Carlo Morosi MD Erika Pace MD Vivian Tang MD Max M. van Noesel MD Andrea Ferrari MD Rick van Rijn MD 《Cancer》2024,130(4):597-608